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The lungs are frequently challenged by viruses, and resident CD8
 
 
 
 T cells likely contribute to 
the surveillance of these pathogens. To obtain insight into local T cell immunity to respiratory 
viruses in humans, we determined the specificity, phenotype, and function of lung-residing 
CD8
 
 
 
 T cells and peripheral blood CD8
 
 
 
 T cells in a paired analysis. The lung contained 
markedly higher frequencies of influenza (FLU)-specific and respiratory syncytial virus (RSV)-
specific CD8
 
 
 
 T cells when compared with the circulation. This contrasted with an equal 
distribution of cytomegalovirus- and Epstein-Bar virus–specific CD8
 
 
 
 T cells. Noticeably, a 
substantial fraction of the lung-residing FLU- and RSV-specific CD8
 
 
 
 T cells had progressed to 
a relatively late differentiation phenotype, reflected by low expression of CD28 and CD27. 
Lung-derived FLU-specific CD8
 
 
 
 T cells had low activation requirements, as expansion of these 
cells could be initiated by cognate peptide in the absence of helper cell–derived signals. Thus, 
the human lung contains high numbers of differentiated FLU- and RSV-specific memory CD8
 
 
 
 
T cells that can readily expand upon reexposure to virus. Resident lung T cells may provide 
immediate immunological protection against pulmonary virus infections.
 
The mucosal surface of the respiratory tract
supplies a large area for the entrance of viruses.
Still, although frequently challenged, the respi-
ratory tract is normally kept free from overt
infections. The human lung parenchyma and
the airways harbor, next to cells of the innate
immune system, high numbers of T lympho-
cytes that may contribute to the local defense
against these viruses. Indeed, several studies
have shown high numbers of T cells in the
lungs and provided support for local T cell acti-
vation in bronchoalveolar lavage and sputum of
healthy individuals, as well as in the context of
such inflammatory pulmonary diseases as chronic
obstructive pulmonary disease, asthma, and in-
terstitial lung diseases (1–5). Compared with
the circulating pools, increased expression of
the activation antigen CD69 is found on both
CD4
 
 
 
 and CD8
 
 
 
 T cells derived from the
lungs (3). Moreover, the strong ability to pro-
duce the effector cytokine IFN-
 
  
 
infers that
local T cells are equipped to rapidly combat
emerging pulmonary viral infections (6). How-
ever, at this moment, it is unclear to what ex-
tent T cells specific for respiratory viruses reside
in the human lung and how they may contribute
to local defense mechanisms.
Most data on the development of antiviral
CD8
 
 
 
 T cell responses and their role in the
protection against viral infections have been
retrieved from animal studies (7). After primary
infection, naive T cells expand and differentiate
into cytotoxic effector cells that are able to
eliminate virus-infected cells. After viral clear-
ance, the effector T cell pool contracts and a
virus-specific memory T cell pool persists that
can undergo rapid reactivation after reinfection.
Concerning respiratory viruses, these memory
cells persist both in secondary lymphoid organs
and the lung (8, 9). Reinfection not only re-
cruits virus-specific memory cells from the
secondary lymphoid organs to the lungs, but it
also induces the rapid expansion of local virus-
specific memory cells (10). Therefore, protective
immunity against respiratory viral infections may
to a significant extent result from reactivation of
CD8
 
 
 
 memory T cells localized in the lungs.
Through MHC/peptide-tetramer technol-
ogy, the buildup of human virus–specific CD8
 
 
 
T cell responses can be analyzed (11). Function-
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ally different types of memory T cells can be discerned with re-
spect to the expression of the cell surface molecules IL-7R
 
 
 
,
CCR7, CD28, and CD27, as well as molecules involved in
cytotoxicity, such as perforin and granzyme B (12). Marked
differences have been detected between virus-specific cells re-
active toward acute viruses, including the respiratory viruses
influenza (FLU) and syncytial virus (RSV), and CD8
 
 
 
 T cells
recognizing herpesviruses, such as CMV. Circulating CD8
 
 
 
 T
cells specific for acute viruses, as FLU and RSV, maintain high
CD27, CD28, and IL-7R
 
 
 
 expression (13, 14), do not contain
cytotoxic molecules, and have been typified as early memory
T cells (15). On the other side of the spectrum, most circulat-
ing CMV-specific T cells have a late differentiation phenotype
characterized by down-regulation of CD28, CD27, and to a
large extent IL-7R
 
 
 
, and constitutive cytotoxicity ability (12,
15, 16). These data suggest that different viruses elicit distinct
functional subsets of CD8
 
 
 
 T cells that have evolved to gener-
ate protective immunity to these pathogens.
In this study, we had the unique opportunity to investigate
the presence and function of virus-specific cells in the human
lung to acquire knowledge on the contribution of local T cell
immunity in protecting humans from respiratory viruses.
 
RESULTS
Lung-residing CD4
 
  
 
and CD8
 
 
 
 
 
T cells show 
an activated phenotype
 
To determine the activation state of total lung CD4
 
 
 
 and
CD8
 
 
 
 T cells, the expression of the activation marker HLA-
DR was analyzed on lung and circulating T cells. HLA-DR
expression was significantly higher on CD8
 
 
 
 and CD4
 
 
 
 T
cells in the lung than in the peripheral blood (HLA-DR on
CD8
 
 
 
 cells, P 
 
 
 
 0.004; HLA-DR on CD4
 
 
 
 cells, P 
 
 
 
 0.03;
Fig. 1 A). In addition to HLA-DR, the conversion of
CD45RA to its isoform CD45R0 has also been associated
with antigen-induced T cell activation (17). In accordance
with prior contact with antigen, lung-residing CD4
 
 
 
 and
CD8
 
 
 
 T cells displayed a significantly lower expression
of CD45RA when compared with circulating T cells
(CD45RA on CD8
 
 
 
 cells, P 
 
 
 
 0.0009; CD45RA on CD4
 
 
 
cells, P 
 
 
 
 0.001; Fig. 1 B).
 
Lung-derived CD4
 
 
 
 and CD8
 
 
 
 
 
T cells have a differentiated 
memory phenotype
 
Because the respiratory tract is continuously challenged by
invading respiratory pathogens, the appearance of activated
CD4
 
 
 
 and CD8
 
 
 
 T cells in the lung raises the question of
whether these cells are part of a local memory T cell pool
and may possibly serve to control respiratory viral infec-
tions. If so, it might be expected that the local T cell popu-
lation contains high frequencies of antigen-experienced
cells but only low numbers of naive T cells. Indeed, few
naive CD8
 
 
 
 T cells, characterized by the CD45RA
 
 
Figure 1. Lung-residing CD4  and CD8  T cells are activated. 
Expression of HLA-DR on CD8  and CD4  T cells (A) and expression of 
CD45RA on CD8  and CD4  T cells (B) on LMCs and PBMCs. Wilcoxon 
matched-pairs signed-rank test.
Figure 2. Lung-residing CD8  T cells show a more differentiated 
phenotype compared with circulating CD8  T cells. Dot plots of CD8  
T cells from PBMCs and LMCs of one representative donor. CD45RA-PE 
fluorescence versus CD27-FITC fluorescence, CD27-PE fluorescence versus 
CD28-FITC fluorescence, anti–IL-7R –PE fluorescence versus CD27-FITC 
fluorescence, and CD27-PE fluorescence versus anti–CCR7-PE fluorescence 
of lymphocytes gated on CD8  T lymphocytes. The dot plots on the left 
represent LMCs, and the dot plots on the right represent PBMCs. 
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CD27
 
bright
 
 phenotype, were found in the lung (Fig. 2, top-
right quadrant; reference 18). Similar data were obtained for
the CD4
 
 
 
 T cell compartment (not depicted). To further
dissect the antigen-primed population, the expression of ad-
ditional differentiation markers on both CD8
 
 
 
 (example
shown in Fig. 2 A) and CD4
 
 
 
 T cells was analyzed. Lung
CD8
 
 
 
 T cells had a significantly lower expression of CD27,
CD28, and IL-7R
 
 
 
 (Figs. 2 and 3A) and had lost expression
of CCR7 (Fig. 2, bottom) compared with matched periph-
eral blood CD8
 
 
 
 T cells. Also in the CD4
 
 
 
 T cell fraction,
the expression of CD27 and CD28 was significantly lower
in the lung than in the circulation (Fig. 3 B). These latter
findings indicate that the populations of CD4
 
 
 
 and CD8
 
 
 
 T
cells in the lung contain cells with a relatively late memory
differentiation phenotype (15).
Studies on circulating T cells have implied that the loss of
CD27 during T cell differentiation coincides with the stable
acquisition of cytotoxic effector molecules (18). We deter-
mined the granzyme B content of CD8
 
 
 
 T cells in the lung
and peripheral blood in a subgroup of donors (
 
n
 
 
 
 
 
 5). Lung
and circulating CD8
 
 
 
 T cells contained comparable frequen-
cies of granzyme B–expressing lymphocytes (percentage of
granzyme B
 
 
 
 CD8
 
 
 
 T cells in the lung: median 9.9, range
1.5–40.6 vs. in PBMCs: median 9.8, range 0.3–31.6). How-
ever, the granzyme B expression in the CD27
 
 
 
 subset was
markedly lower in the lung-derived CD8
 
 
 
 T cells (mean
fluorescence intensity [MFI]: 128.9 median, range 33.8–343)
than in circulating CD27
 
  
 
CD8
 
 
 
 T cells (MFI: 350 median,
range 66.2–1104). An example of a representative donor is
shown in Fig. 4. These data suggest that although pulmonary
CD8
 
 
 
 T cells have the phenotypic characteristics of more
differentiated CD27
 
 
 
 
 
CD28
 
 
 
 cells, they did not yet acquire
complete cytotoxic potential.
The expression of IL-7R
 
 
 
 is down-regulated on virus-
specific T cells during acute antiviral responses (19, 20). Ad-
ditionally, we recently showed that in healthy individuals la-
tently infected with herpesviruses, many T cells specific for
these viruses lack IL-7R
 
 
 
 expression (16). To discriminate
between these two entities, we determined the activation
status of lung IL7R
 
 
 
 
 
 CD8
 
 
 
 T cells in two donors. We
found that a substantial part of the IL-7R
 
 
 
 
 
 cells expressed
HLA-DR (the percentages of HLA-DR
 
 
 
 cells of total
CD8
 
 
 
 IL-7R
 
 
 
 
 
 cells were 62 and 72%), indicating that to a
considerable extent, local immune activation is responsible
for the presence of IL-7R
 
 
 
 
 
 cells.
 
Relative enrichment of differentiated FLU- and RSV-specific 
memory CD8
 
 
 
 T cells in the lung
 
To evaluate the specificities of lung-residing T cells, the fre-
quency of CMV-, EBV-, FLU-, and RSV-specific CD8
 
 
 
 T
cells was determined by HLA/peptide tetramers (Table I). A
significantly higher percentage of FLU tetramer
 
 
 
 CD8
 
 
 
 T
cells in the lung (percentage of tetramer
 
 
 
 cells within CD8
 
 
 
cells: median 1.2, range 0.2–10.0) compared with their
equivalents in the peripheral blood (median 0.06, range
0–0.3; P 
 
 
 
 0.002) was found. Also, the percentage of RSV
tetramer
 
 
 
 CD8
 
 
 
 T cells tended to be higher in the lung
(median 0.3, range 0.09–1.9) when compared with the pe-
Figure 3. Lung-residing CD8  T cells show a more differentiated 
phenotype compared with circulating CD8  T cells. Scatter plot showing 
the expression of IL-7R , CD27, and CD28 on CD8  T cells (A) and CD4  
T cells (B) on LMCs and PBMCs. Wilcoxon matched-pairs signed-rank test.
Figure 4. Lung-derived CD27  CD8  T cells have a lower granzyme 
B content than circulating CD27  CD8  T cells. (A) Histograms of CD8 
expression (LMC on the left and PBMC on the right). The horizontal line 
indicates the gate for CD8 bright lymphocytes (top). Histogram of CD27 
expression gated on CD8 bright cells (bottom). The horizontal line indicates 
the gate for CD27  and CD27  cells. (B) Histogram of granzyme B expression 
gated on CD8  CD27  cells (left) and CD8  CD27  cells (right). The solid 
line represents LMC, and the dashed line represents PBMCs. The numbers 
indicate the MFI for granzyme B. An example of one representative exper-
iment is shown.VIRUS-SPECIFIC CD8  T CELLS IN THE HUMAN LUNG | de Bree et al. 1436
ripheral blood (median 0.02, range 0–0.04; P   0.12). In
contrast, frequencies of EBV- (lung: median 1.0, range 0.2–
11.0) and CMV-specific T cells (lung: median 2.4, range
0.07–4.3) did not differ from those in the circulation (EBV:
median 0.9, range 0.2–2.5; CMV: median 1.9, range 0.8–
12.4; P   0.6 and P   0.6, respectively; Fig. 5). Because the
lung T cell pool contains, in contrast to the circulating T cell
pool, very few naive cells, this might distort the observed ac-
cumulation of FLU- and RSV-specific cells in the lung.
Therefore, we corrected the percentages of tetramer  cells in
PBMCs and LMC for the fraction of naive (CD45RA 
CD27bright) cells in PBMCs and lung mononuclear cells
(LMCs). However, this correction did not change the signif-
icance levels of the previous observations (Table II).
Based on their functional properties and CD27  CD28 
CCR7  phenotype, circulating FLU- and RSV-specific
CD8  T cells have recently been characterized as memory T
cells with an early differentiation phenotype (13, 14). In a
subgroup of donors, the characteristics of lung- and PBMC-
derived FLU- (n   9), RSV- (n   5), CMV- (n   4), and
EBV- (n   4) specific cells were analyzed by tetramer stain-
ing (example shown for two donors for FLU and EBV in
Fig. 6). Lung-residing FLU-specific T cells had a low ex-
pression of CD28 but had retained a relatively high expres-
sion of both CD27 and IL-7R  (Fig. 7). In contrast, in all
donors eligible to analysis, RSV-reactive CD8  T cells in
the lung had low expression of both CD28 and CD27 (Fig.
7). In addition, we determined in three donors whether
lung-derived FLU- and RSV-specific CD8  cells contained
granzyme B (shown for two donors in Fig. 6 E). In all three
donors, the tetramer  cells showed a very low granzyme B
expression (median percentage of granzyme B  cells gated
on tetramer  cells was 3.6, range 3.5–12.5). Taken together,
these data indicate that despite the loss of CD28 and CD27,
FLU- and RSV-specific cells are noncytotoxic memory
cells. Furthermore, simultaneous analysis of the cell cycle
marker Ki-67 and FLU tetramers showed that all tetramer 
cells were Ki-67 , indicating that local FLU-specific cells are
not actively replicating (not depicted). In contrast, the dis-
tinctions between local and circulating FLU- and RSV-spe-
cific T cells and CMV- and EBV-specific CD8  T cells
showed a similar expression of CD27 and CD28 on LMCs
and PBMCs (Figs. 6 and 7).
Lung-residing FLU-specific CD8  T cells do not need 
additional stimulation by common   chain 
cytokines to expand
A central feature of virus-specific memory CD8  T cells is
their ability to expand upon reencountering antigen. We
studied whether lung-derived virus-specific CD8  T cells
differed from circulating virus-specific T cells with respect to
their proliferative requirements. To this end, we labeled
LMCs or PBMCs of the same donor with carboxyfluores-
cein diacetate succinimidyl ester (CFSE) and cultured them
in the presence of peptide or with peptide in combination
Table I. MHC class I tetramers
HLA-type specificity Virus Sequence Reacting donors
A*0101 RSV YLEKESIYY 5/8a
A*0101 FLU CTELKLSDY 5/8
A*0201 FLU GILGFVFTL 5/12
A*0201 CMV NLVPTMVATV 2/12
B7 CMV TPRVTGGGAM 2/4
B7 EBV RPPIFIRRL 2/4
B8 EBV RAKFKQLL 2/4
aNumber of donors reacting with the tetramer/number of donors with HLA-type 
matching the tetramer.
Figure 5. Paired analysis of the frequency of FLU-, RSV-, CMV-, 
and EBV-specific CD8  T cells in the lung and PBMCs. The frequencies 
of virus-specific cells are expressed as the percentage of tetramer  cells 
within CD8  T cells (y axis). In 4 of the 10 donors analyzed with FLU tetra-
mers and 3 out of the 5 donors analyzed with RSV tetramers, tetramer  
cells could not be detected in the PBMC. Wilcoxon matched-pairs signed-
rank test. The differences in percentages of RSV-, CMV-, and EBV-specific 
CD8  T cells within the lung and PBMCs were not statistically significant.
Table II. Percentages of nonnaive tetramer  cells in the lung and PBMCs
virus
% of tetramer  cells within
nonnaive CD8  cells in lunga
% of tetramer  cells within
nonnaive CD8  cells in PBMCs p-valueb
FLU 1.20 (0.3–11.6)c 0.16 (0–0.34) 0.002
RSV 0.35 (0.12–2.0) 0 (0–0.07) 0.06
EBV 0.9 (0.3–11.3) 0.98 (0.22–2.42) 0.6
CMV 2.4 (0.07–5.0) 2.05 (0.2–12.9) 1.0
aPercentage of nonnaive cells is calculated by correcting the percentage of total CD8  cells for the percentage of naive (CD45RA  CD27bright) cells.
bWilcoxon matched-pairs signed-rank test.
cMedian (range).JEM VOL. 202, November 21, 2005 1437
ARTICLE
with IL-2, IL-7, or IL-15. After 6 d, the mean number of
cell divisions of divided tetramer  cells was calculated.
Lung-derived FLU-specific cells appeared to expand better
in vitro by stimulation with FLU peptide alone (mean num-
ber of cell divisions for LMCs: median 1.8, range 1.3–2.2;
PBMCs: median 0.5, range 0–1.0), whereas PBMC-derived
FLU-specific cells needed the addition of IL-2, IL-7, or IL-
15 to induce proliferation of FLU-specific cells (Fig. 8 and
Table III). The proliferative requirements of EBV- and
CMV-specific CD8  T cells derived from the lung were,
however, comparable with EBV- and CMV-specific CD8 
T cells derived from PBMCs (Table III).
We tested whether the higher proliferative capacity of
lung-derived FLU-specific cells was an intrinsic T cell prop-
erty or alternatively related to differences in the composition
of antigen-presenting cells between lung and blood. From
two donors (Fig. 8 A, donors 1 and 2), total CD8  T cells of
paired PBMC and LMC samples were sorted and labeled
with CFSE. Autologous PBMCs were loaded with FLU
peptide, irradiated, and used as stimulators for those purified
CD8  T cells (shown for one representative donor in Fig. 8
C). After 7 d, the mean number of cell divisions of divided
tetramer  cells was calculated as described in Materials and
methods (see below). The mean number of cell divisions of
lung-derived FLU-specific cells was higher in both donors
(2.8 and 2.0 in the lung and 1.0 and 1.0 in PBMCs, respec-
tively) than those of PBMC-derived FLU-specific cells.
These experiments show that the higher proliferative capac-
ity of FLU-specific lung-derived CD8  T cells is a property
of these cells.
DISCUSSION
In this study, we show that the human lung contains a large
pool of FLU- and RSV-specific CD8  T cells. These local
CD8  T cells specific for respiratory viruses have progressed
to a differentiated memory state that is characterized by a
partial loss of CD27 and CD28, but preserved IL-7R  ex-
pression. Antigen-specific reactivation in vitro of lung-
derived FLU-specific CD8  T cells resulted in a potent pro-
liferative response without a strict need for additional help
from common   chain cytokines.
The respiratory tract is the primary target for entry of respi-
ratory viruses. Although data on healthy individuals are lack-
ing, studies in patients at risk for developing respiratory virus
infections have demonstrated that the airways harbor a broad
spectrum of viruses, such as rhinoviruses and RSV (21, 22).
Because these viruses hardly induce clinical symptoms under
physiological conditions, the lung immune system must be
Figure 6. FLU tetramer  cells in the lung show a lower expression 
of CD27 and CD28 and a similar IL-7R  expression compared with 
circulating FLU tetramer  cells, whereas the CD27, CD28, and IL-7R  
expression on EBV tetramer  cells in the lung resembles that of 
tetramer  cells in the blood. Representative dot plots of a donor stained 
with the FLU-A1 tetramer (A and B) and a donor stained with the EBV-B7 
tetramer (C and D). Dot plot of CD8–PerCP-Cy5.5 fluorescence versus FLU-A1–
tetramer-APC (A) or EBV-B7–tetramer-APC (C) gated on total lymphocytes 
in the LMCs (left) and PBMCs (right; B and D). (E) RSV- and FLU-specific 
cells in the lung do not contain granzyme B. Dot plots of LMCs of two 
donors reacting with the RSV-A1 tetramer (dot plots on the left) or FLU-A2 
tetramer (dot plots on the right) are shown. The top dot plots show CD8 
versus RSV or FLU tetramer staining. The quadrant represents the gate for 
tetramer  cells. The bottom dot plots show granzyme B versus CD27 
expression. CD8  T cells are shown in gray, and tetramer  CD8  T cells are 
shown in black. The numbers indicate percentages within tetramer  cells 
in the corresponding quadrants.
Figure 7. FLU and RSV tetramer  CD8  T cells in the lung show a 
lower expression of CD28 and CD27 compared with their circulating 
counterparts, but retain a high IL-7R  expression. Scatter plots 
showing the expression of IL-7R , CD27, and CD28 on CMV tetramer  CD8  T 
cells (top left), EBV tetramer  CD8  T cells (top right), FLU tetramer  CD8  T 
cells (bottom left), and RSV tetramer  CD8  T cells (bottom right).VIRUS-SPECIFIC CD8  T CELLS IN THE HUMAN LUNG | de Bree et al. 1438
well adapted to eliminate and restrain infections, probably in-
volving CD4  and CD8  T cells as key players. Several studies
have indicated that local T cells exhibit activation characteris-
tics (2, 3, 5). In line with other studies (23), we found that the
lung has an enrichment of CD45RA  CD4 T cells, indicating
that the CD4  T cell pool in the lung consists mainly of mem-
ory-type cells. To discriminate between naive CD8  T cells
and memory CD8  T cells, single CD45RA analysis is unsuit-
able because not only do naive CD8  T cells express
CD45RA (18), but effector-type CD8  T cells do as well. In
fact, this might explain the broader range in CD45RA expres-
sion on lung-derived CD8  cells when compared with the
CD45RA expression on lung CD4  T cells (Fig. 1 B). Naive
CD8  T cells can, however, be accurately defined as
CD45RA  CD27bright  (18). Lymphocytes in the lung showed
a markedly lower fraction of naive CD8  CD45RA 
CD27bright  cells than circulating CD8  T cells. Additionally,
all lung-residing T cells lacked the chemokine receptor CCR7
in accordance with the notion that predominantly nonnaive T
cells using other chemokine receptors migrate to the lung.
Figure 8. Lung-residing FLU tetramer  CD8  T cells proliferate 
better than circulating FLU tetramer  CD8  T cells. Total PBMCs and 
LMCs of three donors were cultured for 6 d with FLU-A1 peptide alone 
(A and top panel in B), or with peptide in combination with IL-2, IL-7, or 
IL-15 (shown for one donor in B). Dot plots show FLU-A1–tetramer versus 
CFSE gated on total CD8  T cells. Dot plots of one representative experiment 
are show in the top right panels. Dot plot shows FLU tetramer versus CFSE. 
Top dot plots show sorted CD8  T cells cultured in the presence of 
autologous, irradiated PBMCs. Bottom dot plots show sorted CD8  T 
cells stimulated with irradiated PBMCs loaded with FLU peptide. Numbers 
indicate the mean number of divisions of divided tetramer  cells (see also 
Materials and methods).
Table III. Median of mean numbers of cell divisions of divided tetramer  cells after in vitro stimulation
FLU lung FLU PBMCs
EBV CMV
lung
EBV CMV
PBMCs
peptide 1.8 (1.3–2.2)a 0.5 (0–1.0)a 1.3 (1.2–1.4) 1.1 (1.0–1.2)
IL-2   peptide 3.0 (2.7–4.6) 3.2 (1.9–5.0)b 3.6 (2.4–3.7) 4.3 (4.2–9)
IL-7   peptide 2.5 (2.1–3.4) 2.8 (1.9–3.7) 2.5 (1.4–2.7) 1.9 (1.5–4.5)
IL-15   peptide 2.7 (2.5–3.0) 3.0 (1.8–3.7) 2.3 (2.2–3.0) 4.0 (3.0–6.8)
Mean number of divisions of divided cells (see also Materials and methods) of CD8  tetramer  cells after culturing for 6 d with peptide alone or in combination with IL-2, IL-7, 
or IL-15. Three donors that responded with the CMV (2) or EBV (1) tetramer, and four donors that responded with FLU tetramers were analyzed.
aP   0.25; Wilcoxon matched-pairs signed-rank test.
bMedian (range).JEM VOL. 202, November 21, 2005 1439
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All T cell populations analyzed were derived from tissue
specimens from patients undergoing surgery for a localized
solitary peripheral lung carcinoma. Because the lung tissue
used for analysis in this study was taken at a far distance from
the carcinoma, we consider it unlikely that the malignancy
had an impact on the activation state of virus-specific cells.
We found that the total CD8  T cell pool contained a large
fraction of recently activated HLA-DR  cells with a low ex-
pression of IL-7R . Because IL-7R  is down-modulated
upon TCR triggering, it can be assumed that the low IL-
7R  expression on activated CD8  T cells in the lung might
be caused by recent viral exposition (16, 20). Viruses that
preferentially infect the respiratory tract are candidates for
the emergence of activated virus-specific lung T cells. A sig-
nificant accumulation of FLU- and, to a lesser extent, RSV-
specific CD8  T cells in the lung was found. However,
these FLU- and RSV-specific cells retained a high IL-7R 
expression and did not acquire granzyme B (Fig. 6, E and 7),
which indicates that these viruses presumably do not con-
tribute to the activation of the large virus-specific CD8  T
cell pool in the lung. The limited availability of tetramers for
a restricted number of viruses narrows the analysis of CD8 
T cells specific for other respiratory viruses. Therefore, we
could not evaluate the fraction of CD8  T cells specific for
such other common respiratory viruses as rhinoviruses or ad-
enoviruses that may possibly contribute to the accumulation
of activated CD8  T cells in the lung.
Prior human studies have focused on the properties of vi-
rus-specific CD8  T cells specific for latent and cleared viruses
(7, 12, 15) in the circulation. It is, however, conceivable that
the compartment in which virus-specific cells reside leaves an
impact on their differentiation characteristics. The low CD28
and CD27 expression on total lung CD8  T cells indicates
that these cells have progressed further along the presumed
differentiation pathway (12, 15) than the circulating CD8  T
cell pool. The differentiation process of CD8  T cells to effec-
tor cells is characterized by loss of CD27 and acquisition of cy-
totoxic effector molecules as granzyme B. Recent studies have
shown that the emergence of cytotoxic CD8  T cells in the
circulation is highly associated with CMV latency, suggesting
that interaction with CMV antigen drives the formation of
cytotoxic cells in the circulation (24, 25). In the lung, we
found markedly lower granzyme B content in the CD8 
CD27  T cell fraction when compared with the CD8 
CD27  fraction in the circulation. Although it remains specu-
lative which viruses drive the differentiation of CD27  CD8 
T cells in the lung, it cannot be excluded that CMV is unique
in that it elicits T cells with high cytotoxic capacity. The lim-
ited granzyme B amount in CD27  cells may suggest that in
the lung, where there is frequent antigenic exposure, other
factors, such as the antigenic environment and cytokine mi-
lieu, may suppress the evolvement of cytotoxic capacity in
fully differentiated virus-specific T cells to some extent.
Loss of CD28 and CD27 has been related to prolonged
antigenic stimulation (26, 27). During differentiation, virus-
specific CD8  T cells have been shown to first lose CD28
from their cell surface, followed by loss of CD27 upon fur-
ther differentiation (28). The low expression of CD28 on
FLU-specific CD8  cells (Fig. 7) indicates that FLU-specific
cells in the lung have reached an intermediate differentiation
state. In addition to low CD28 expression levels, RSV-spe-
cific cells in the lung also have low CD27 expression levels,
suggesting that RSV-specific cells are relatively further dif-
ferentiated than FLU-specific cells. The only known mecha-
nism that induces a CD27  phenotype is antigen-induced
interaction between CD27 and its ligand CD70 (29, 30). In
this respect, the observation that CD27 expression on lung T
cells is markedly lower on RSV than on FLU-specific T cells
might imply that humans are intermittently but relatively
frequently exposed to RSV. CD70 is induced by the pres-
ence of antigen and can be modulated by cytokines, such as
IL-2 and IL-15 (28–30). The presence of a large population
of activated CD4  memory cells in the lung (Fig. 1) may
provide a source of IL-2. In addition, a study by Muro et al.
(31) showed high IL-15 mRNA expression in the lung of
healthy individuals even under inflammatory conditions. Over-
all,  our data indicate that the appearance of virus-specific
CD8  T cells in the lung compartment might be shaped on the
one hand by the presence or frequent contact with its cognate
antigen and on the other hand by the local cytokine milieu.
An important feature of memory cells is the ability to
persist in the absence of antigen. After elimination of the vi-
rus, a large fraction of virus-specific effector cells undergoes
apoptosis and a smaller fraction of memory cells is main-
tained. In the search for factors that may determine which
memory cells are maintained, the expression of the IL-7R 
on virus-specific cells is associated with properties of long-
lived memory cells (20). In humans, the expression of IL-
7R  is down-modulated upon T cell receptor triggering
(16). We found that CMV-specific cells in the lung did not
differ in IL-7R  expression from circulating CMV-specific
cells. EBV-specific cells tended to have a lower expression in
the lung when compared with peripheral blood. In contrast,
FLU- and RSV-specific cells retained a high IL-7R  ex-
pression in the lung. Currently, there are no data available
on the regulation and role of IL-7R  on tissue-residing vi-
rus-specific T cells. Therefore, it remains speculative as to
whether the IL-7R  is also down-modulated in tissues upon
antigen-specific activation as has been described in relation
to circulating virus-specific T cells (16). When we extrapo-
late these findings to the high expression of IL-7R  on
FLU- and RSV-specific cells in the lung, we might hypoth-
esize that these cells are, but not continuously, activated by
their cognate antigen and may rely on IL-7 for their mainte-
nance in the absence of antigen.
An essential property of memory cells is their ability to
rapidly expand upon antigen challenge. It has been shown
that next to antigen, in vitro cytotoxic as well as memory T
cells need additional factors to proliferate (32, 33). Lung-
derived FLU-specific cells proliferated better than circulating
FLU-specific cells in response to stimulation with peptide
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sponse to in vitro peptide stimulation has been shown to de-
pend on the persistence of the antigen (34). It was found that
memory cells that were continuously exposed to antigen
proliferated less well in response to viral peptide in vitro than
memory cells specific for a cleared virus. As mentioned ear-
lier, the high expression level of IL-7R  on FLU-specific
cells suggests that lung-derived FLU-specific cells are not
persistently in contact with FLU. Together with the obser-
vation that local FLU-specific cells are partly CD27 , it
might be expected that they are activated by viral epitopes
intermittently. Frequent subclinical reexposure to FLU (or
RSV) may result in a differentiated state of the memory cells
and may lower the threshold for antigen-induced expansion.
A central issue in understanding local T cell immunity is
whether virus-specific CD8  T cells reside in the lung and
are locally reactivated upon infection, or whether circulating
virus-specific CD8  T cells are recruited from the circula-
tion. Direct measurements on the contribution of either
mechanism are impossible to perform in humans. However,
extensive studies in mice have shown that defense against a
secondary pulmonary FLU infection is achieved mainly by
reactivation of local FLU-specific CD8  T cells, and to a
lesser extent by recruitment of circulating virus-specific cells
(8, 9). The large percentage of differentiated FLU- and
RSV-specific CD8  cells in the human lung, in contrast to
very low frequencies in the circulation, combined with the
observation that the lung contains ample numbers of acti-
vated (i.e., DR ) cells suggests that in the human lung, re-
curring respiratory infection is also guarded by the local resi-
dent T cell pool.
In sum, our data show that the characteristics of FLU-
and RSV-specific T cells in the human lung differ from
those in the blood. The lung contains pools of differentiated
respiratory virus-specific CD8  T cells that are potentially
on standby to provide immediate defense against respiratory
infections. Because the primary aim of immune boosting by
vaccination is the effective expansion of the virus-specific
memory T cell compartment, the data in this study point out
that it may be worthwhile to consider vaccination strategies
for respiratory viruses that target T cells in the lung.
MATERIALS AND METHODS
Donors. 22 subjects (median age 70, range 47–77) undergoing lobectomy
for a localized solitary peripheral lung carcinoma were included. All patients
were free of symptoms of upper respiratory tract infection and did not re-
ceive antibiotics 2 wk before inclusion in the study. 5 out of 22 patients had
a history of cardiopulmonary disease. Of those patients, two had diabetes.
None of the patients suffered from renal failure. None of the patients in this
study received systemic corticosteroids or other immunosuppressive therapy
at the time of inclusion in the study or in the past. Furthermore, none of the
patients received chemotherapeutic treatment. All of the 22 subjects were
(ex-) smokers. Of them, six smoked on the moment of analysis. These six
subjects did not show differences in responses in relation to the nonsmoking
individuals in this study. All participants aged  65 yr (n   15) had been im-
munized with the yearly FLU vaccine. Additionally, we determined whether
there were differences in the frequencies of FLU-specific cells between vac-
cinated and nonvaccinated individuals. This was not the case (PBMC: P  
0.9; lung: P   0.9; Mann-Whitney). Patients were recruited from the Aca-
demic Medical Center, Amsterdam, and the Hilversum Hospital, Hilversum,
Netherlands. All participants gave written informed consent before inclusion
in the study, which was approved by the Medical Ethics Committee of the
Academic Medical Center of the University of Amsterdam.
Isolation of PBMCs and HLA typing. Heparinized venous blood sam-
ples were obtained 1 d before surgery. PBMCs were isolated by standard
density gradient techniques and cryopreserved until analysis. HLA typing
for HLA-A1, HLA-A2, HLA-B7, and HLA-B8 was performed by PCR
(Table I).
Isolation of mononuclear cells from lung tissue. LMCs were isolated
from lung tissue as described by Holt et al. (35). In brief, 1   1 cm tissue
specimens were sliced to 1 mm and incubated for 20 min in RPMI contain-
ing 20 mM Hepes, 15% (wt/vol) FCS, and 50 U/ml DNase (Sigma-
Aldrich) while shaking at 37 C. A second incubation step, 60 min while
shaking at 37 C, was performed in the same medium supplemented with
300 U/ml collagenase. A cell suspension of lung tissue was obtained by
grinding the tissue through a flow-through chamber. Erythrocyte counts
were confirmed to be  5% of erythrocyte counts in the paired blood sam-
ple. Mononuclear cells were isolated from the lung homogenate by standard
density gradient techniques and cryopreserved until analysis. The yield of 1
cm3 of lung tissue was generally 10   106 mononuclear cells.
Tetrameric complexes. The following HLA–peptide tetrameric com-
plexes were provided by K. Tesselaar and D. van Baarle (Sanquin, Amster-
dam, Netherlands): HLA-A2 tetramer loaded with the CMV pp65-derived
NLVPMVATV peptide, HLA-B7 tetramer loaded with the CMV pp65-
derived TPRVTGGGAM peptide, HLA-B7 tetramer loaded with EBV
EBNA3A-derived RPPIFIRRL peptide, HLA-B8 tetramer loaded with
EBV BZLF1-derived RAKFKQLL peptide, HLA-A2 tetramer loaded with
FLU M1-derived GILGFVFTL peptide, and HLA-A1 tetramer loaded with
RSV M-derived YLEKESIYY peptide. HLA-A1 tetramer loaded with FLU
NP-derived CTELKLSDY peptide was obtained from Proimmune. All tet-
ramers used were allophycocyanin-conjugated. In Results, the different tet-
ramers are named after the virus and the HLA type, e.g., CMV A2 tetramer.
Flow cytometric analysis. PBMC or LMC (0.5   106 cells) were incu-
bated with tetrameric complexes and different combinations of the follow-
ing antibodies: CD27-FITC (homemade clone 3A12), HLA-DR-FITC
(Becton Dickinson), CD69-FITC (Becton Dickinson), CD45RA-PE (San-
quin), CD28-PE (BD Biosciences), anti–CCR7-PE (Becton Dickinson),
anti–IL-7R –PE (Immunotech), CD38-PE (Becton Dickinson), CD8–
PerCP-Cy5.5 (Becton Dickinson), and CD4–PerCP-Cy5.5 (Becton Dick-
inson). Cells were labeled according to the manufacturers’ instructions,
washed with PBS containing 0.01% (wt/vol) NaN3 and 0.5% (wt/vol) bo-
vine serum albumin (PBA).
Intracellular Ki-67 and granzyme B staining was performed by incubat-
ing 0.5   106 PBMCs or LMCs with tetrameric complexes and combina-
tions of antibodies CD27-FITC (homemade clone 3A12) and CD8-PerCP
(Becton Dickinson), washed once, fixed with 50  l buffered formaldehyde
aceton solution, and then permeabilized by washing with 0.1% saponin and
50 mM D-glucose. Cells were then incubated with anti–Ki-67–FITC (Da-
koCytomation) or anti–granzyme-B–PE (Sanquin) antibodies. Cells were
analyzed using a FACSCalibur flow cytometer and CellQuest Pro software
(BD Biosciences).
CFSE labeling. PBMCs and LMCs were labeled with 0.5  M CFSE (In-
vitrogen) in PBS for 10 min, with shaking at 37 C. Cells were washed and
resuspended in IMDM containing 10% human pool serum and antibiotics.
Activation of total LMC- and PBMC-derived T cells. CFSE-labeled
cells were cultured in culture medium (IMDM containing 10% [wt/vol] hu-
man pool serum and antibiotics) for 6 d in a 48-well plate at a concentrationJEM VOL. 202, November 21, 2005 1441
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of 0.5   106 cells/ml per well. Cells were stimulated with the specific CMV,
FLU, RSV, or EBV peptide alone, or in combination with CMV, FLU, or
RSV antigen (all 10  l/ml; Microbix Biosystems Inc.), or either 50 U/ml
IL-2 (Biotest Ag), 10 ng/ml IL-7 (Strathmann), or 10 ng/ml IL-15 (R&D
Systems). Peptides were added at a final concentration of 1.25  g/ml. Flow
cytometric analysis was performed after 6 d. The mean number of divisions
of the divided cells was calculated as follows. First, based on the CFSE histo-
gram gated on total CD8  cells (Fig. S1 A, available at http://www.jem.org/
cgi/content/full/jem.20051365/DC1), markers were set on each cell divi-
sion. Next, the marker settings were copied to the CFSE histogram gated on
tetramer  cells of the same culture (Fig. S1 B), and the cell numbers in each
division were determined (n) and used for calculation with the following for-
mula: [ n 1(n Pn/2n)]/[ n 1(Pn/2n)] (n is the number of cell divisions, and P
is the number of cells in each division) (16).
To obtain pure CD8  T cells, LMCs and PBMCs were sorted in a
CD8  fraction using a FACSAria (BD Biosciences). Sorted CD8  cells
were labeled with CFSE and cocultured with irradiated autologous PBMCs
that were loaded with FLU A2 peptide for 2 h at 37 C. Irradiated autolo-
gous cells were added to purified CD8  T cells in a ratio of 50,000–20,000
per well and cultured for 7 d in a 96-well plate. Flow cytometric analysis
was performed, and the mean number of divisions of the divided cells was
calculated as described above.
Statistical analysis. The comparisons made in this study imply the assess-
ment of differences between lung and peripheral blood within patients,
which typically results in a matched-pairs situation. The statistical test used
is the nonparametric Wilcoxon matched-pairs signed-rank test. The tests
were performed with GraphPad Prism software, version 4. The significance
level was set at 0.05.
Online supplemental material. Fig. S1 shows an example of a CFSE
histogram that is used to determine the number of cells in each division. It is
available at http://www.jem.org/cgi/content/full/jem.20051365/DC1.
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